Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscular Atrophy, Spinal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05824169
What this trial is testing

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients

Who this might be right for
Spinal Muscular Atrophy
GeneCradle Inc 18
Not applicableStudy completedNCT01402570
What this trial is testing

Glutathione and Health With Post-Polio Syndrome

Who this might be right for
Post-polio SyndromePhysical ActivityDepression+2 more
University of Michigan 20
Not applicableLooking for participantsNCT05755451
What this trial is testing

Natural History of SMA

Who this might be right for
Muscular Atrophy, Spinal
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,200
Not applicableStudy completedNCT05341453
What this trial is testing

Equine-Assisted Physiotherapy for Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
Charles University, Czech Republic 21
Testing effectiveness (Phase 2)Ended earlyNCT02876094
What this trial is testing

Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy (SMA)
Hugh McMillan 1
Not applicableStudy completedNCT04576494
What this trial is testing

Study of the Functional Effects of Nusinersen in 5q-spinal Muscular Amyotrophy Adults (SMA Type 2 or 3 Forms)

Who this might be right for
Spinal Muscular Atrophy
CHU de Reims 4
Not applicableStudy completedNCT05590754
What this trial is testing

50% Body Weight Reverses Stature, Lumbar Disc Expansion and Vertebral Compliance by Hyper-Buoyancy Floatation.

Who this might be right for
Intervertebral Disc CompressionMuscle AtrophySpine Injury
Universidad Autonoma de Madrid 16
Not applicableActive Not RecruitingNCT07796776
What this trial is testing

The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition

Who this might be right for
Inclusion Body Myositis (IBM)Motor Neuron Disease, Amyotrophic Lateral Sclerosis
IRCCS San Raffaele 30
Not applicableNot Yet RecruitingNCT07530926
What this trial is testing

Adrenal& Bone Complications in Paediatric Patients Living With Spinal Muscular Atrophy (SMA)

Who this might be right for
SMA - Spinal Muscular Atrophy
Sheffield Children's NHS Foundation Trust 550
Early research (Phase 1)Study completedNCT02052791
What this trial is testing

An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in ISIS 396443-CS2 (NCT01703988) or ISIS 396443-CS10 (NCT01780246)

Who this might be right for
Spinal Muscular Atrophy
Biogen 47
Not applicableUnknownNCT00155168
What this trial is testing

Quantitative Analysis of SMN1 and SMN2 Gene Based on DHPLC System

Who this might be right for
Spinal Muscular Atrophy
National Taiwan University Hospital 500
Post-approval studies (Phase 4)Looking for participantsNCT05861986
What this trial is testing

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

Who this might be right for
Muscular Atrophy, Spinal
Hoffmann-La Roche 28
Testing effectiveness (Phase 2)Looking for participantsNCT05747261
What this trial is testing

Study of the Safety and Efficacy of an Adeno-Associated Viral Vector Carrying the SMN Gene After a Single Intravenous Administration of Escalating Doses in Children With Spinal Muscular Atrophy (BLUEBELL)

Who this might be right for
Spinal Muscular Atrophy (SMA)
Biocad 40
Not applicableEnrolling By InvitationNCT06772402
What this trial is testing

GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy Type 2
Genecombio Ltd. 6
Testing effectiveness (Phase 2)Study completedNCT02386553
What this trial is testing

Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
Biogen 25
Not applicableStudy completedNCT02574390
What this trial is testing

Answer ALS: Individualized Initiative for ALS Discovery

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALS+5 more
Johns Hopkins University 1,049
Large-scale testing (Phase 3)Study completedNCT01645787
What this trial is testing

Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients

Who this might be right for
Spinal Muscular Atrophy
Columbia University 11
Not applicableUnknownNCT05521217
What this trial is testing

Myotonometer Intra- and Inter Examiner Reliability on Spinal Muscular Atrophy

Who this might be right for
Muscle Tone PoorSpinal Muscular Atrophy
Istanbul Medipol University Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT05626855
What this trial is testing

Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab

Who this might be right for
Spinal Muscular AtrophySpinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 2+7 more
Scholar Rock, Inc. 238
Not applicableStudy completedNCT04004390
What this trial is testing

Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin

Who this might be right for
Post-Poliomyélitis Syndrom
University Hospital, Montpellier 17
Next Page